ServicenavigationHauptnavigationTrailKarteikarten

Forschungsstelle
INNOSUISSE
Projektnummer
13376.1;5 PFFLE-LS
Projekttitel
Markers for risk to develop atrial fibrillation based on a new electrocardiographic tool
Projekttitel Englisch
Markers for risk to develop atrial fibrillation based on a new electrocardiographic tool

Texte zu diesem Projekt
 DeutschFranzösischItalienischEnglisch
Kurzbeschreibung
-
Anzeigen
-
Anzeigen
Abstract
-
Anzeigen
-
Anzeigen

Erfasste Texte


KategorieText
Kurzbeschreibung
(Englisch)
Markers for risk to develop atrial fibrillation based on a new electrocardiographic tool
Kurzbeschreibung
(Französisch)
Marqueurs de risque de développement de fibrillation auriculaire basés sur un outil électrocardiographique nouveau
Abstract
(Englisch)
Atrial fibrillation (AF) is the most common cardiac arrhythmia and is increasing in the general population with a prevalence in our population of up to 8% over age 75 y. As it is the most important trigger for Heart Failure and Stroke, AF must be considered a major health problem. Reliable methods for indicating risk for AF are lacking and careful analysis of the ECG could improve this process for the sake of individuals but with an impact on the population. P-Wave (atrial signal in the ECG) is considered as the ¿Cinderella of the ECG¿ and has not been evaluated in depth for indicating AF risk. Therefore an advanced analysis of the atrial signal would be an important commercial advantage for the concerned industrial partner.
Abstract
(Französisch)
Atrial fibrillation (AF) is the most common cardiac arrhythmia and is increasing in the general population with a prevalence in our population of up to 8% over age 75 y. As it is the most important trigger for Heart Failure and Stroke, AF must be considered a major health problem. Reliable methods for indicating risk for AF are lacking and careful analysis of the ECG could improve this process for the sake of individuals but with an impact on the population. P-Wave (atrial signal in the ECG) is considered as the ¿Cinderella of the ECG¿ and has not been evaluated in depth for indicating AF risk. Therefore an advanced analysis of the atrial signal would be an important commercial advantage for the concerned industrial partner.